Xiaoqiong Wang, Yao Zhang, Lijuan Zhou, Xiaona Yin, Chuchu Xu, Jiakui Zhang, Fangbin Du, Yongsheng Wang
{"title":"Hemophagocytic lymphohistiocytosis caused by dual mutations in UNC13D and STX11 induced by HHV-7: a case report and review of the literature.","authors":"Xiaoqiong Wang, Yao Zhang, Lijuan Zhou, Xiaona Yin, Chuchu Xu, Jiakui Zhang, Fangbin Du, Yongsheng Wang","doi":"10.1007/s00277-025-06611-8","DOIUrl":null,"url":null,"abstract":"<p><p>Hemophagocytic lymphohistiocytosis (HLH) is a severe disorder caused by excessive activation of the immune system and is characterized by hyperinflammation and life-threatening multiple organ failure. We report a case of a 39-year-old female patient with rapidly progressive disease who presented with pancytopenia, coagulopathy, hepatic dysfunction, and hyperlipidemia. Laboratory tests revealed marked cytopenia, hypofibrinogenemia, hypertriglyceridemia, hyperferritinemia, elevated soluble CD25 levels, decreased natural killer cell activity, and hemophagocytosis in the bone marrow, meeting the diagnostic criteria for HLH. The HLH in this case was triggered by human herpesvirus 7 (HHV-7), which has rarely been reported. Genetic analysis revealed compound heterozygous mutations in two HLH-related genes, UNC13D (c.1232G > A) and STX11 (c.121 C > A), which were inherited from the mother and father, respectively, indicating a diagnosis of familial HLH. Hematopoietic stem cell transplantation remains the most effective treatment for this condition. This case highlights the importance of incorporating genetic testing into the early diagnostic workflow for HLH. Early identification of genetic predisposition is crucial for prognosis assessment and the selection of appropriate treatment strategies to improve clinical outcomes.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-025-06611-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a severe disorder caused by excessive activation of the immune system and is characterized by hyperinflammation and life-threatening multiple organ failure. We report a case of a 39-year-old female patient with rapidly progressive disease who presented with pancytopenia, coagulopathy, hepatic dysfunction, and hyperlipidemia. Laboratory tests revealed marked cytopenia, hypofibrinogenemia, hypertriglyceridemia, hyperferritinemia, elevated soluble CD25 levels, decreased natural killer cell activity, and hemophagocytosis in the bone marrow, meeting the diagnostic criteria for HLH. The HLH in this case was triggered by human herpesvirus 7 (HHV-7), which has rarely been reported. Genetic analysis revealed compound heterozygous mutations in two HLH-related genes, UNC13D (c.1232G > A) and STX11 (c.121 C > A), which were inherited from the mother and father, respectively, indicating a diagnosis of familial HLH. Hematopoietic stem cell transplantation remains the most effective treatment for this condition. This case highlights the importance of incorporating genetic testing into the early diagnostic workflow for HLH. Early identification of genetic predisposition is crucial for prognosis assessment and the selection of appropriate treatment strategies to improve clinical outcomes.
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.